GILEAD SCIENCES, INC. — Director's Dealing 2019

May 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2019-05-01

Reporting Person: Whitley Richard James (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-01	Common Stock	M	9534	$22.015	Acquired	34669	Direct
2019-05-01	Common Stock	S	9534	$65.0235	Disposed	25135	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-01	Non-qualified Stock Option (Right to Buy)	$22.015	M	9534	Disposed	2019-05-06	Common Stock (9534)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: Sale prices reported for the transactions reported here range from $64.49 to $65.47. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F3: The options vested quarterly over the first year of service and were fully vested on May 6, 2010.